


Skye Biologics are at the forefront of advancing regenerative biologic therapies, utilising donor placental tissue to produce a pipeline of therapies aimed at addressing unmet needs across various clinical areas.

Skye Biologics faced significant hurdles with their complex, manual manufacturing process:
After evaluating multiple vendors, Skye Biologics chose Seal.run for a custom, integrated solution. This digital system unified key operations:
Deploying Seal delivered significant improvements and unlocked key insights:
